Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BA.2.85EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.65EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BG.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.61EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.74EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.17.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.562EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.219EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
N.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AZ.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.114EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.199EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.112EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.123EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.143EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.48EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.46.6.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.112.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.360EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.49EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.134EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BY.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CW.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.42EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.46EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
B.1.177.71EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
B.1.1.445EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
AY.21 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used